Research has demonstrated that silencing STX18 expression in A549 and H460 NSCLC cells reduces their resistance to radiation, primarily by disrupting the ATR/CHK1 signaling pathway and affecting the stability of the p53 protein [86,87]. Here, TP53 is linked to non-small cell lung carcinoma.